Calidi Biotherapeutics, Inc.CLDINYSE
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank59
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P59
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 9.90% |
| Q2 2025 | -14.62% |
| Q1 2025 | -21.70% |
| Q4 2024 | 18.94% |
| Q3 2024 | 12.36% |
| Q2 2024 | 20.18% |
| Q1 2024 | 12.20% |
| Q4 2023 | -306.57% |
| Q3 2023 | 83.81% |
| Q2 2023 | -93.45% |
| Q1 2023 | 16.68% |
| Q4 2022 | -44.84% |
| Q3 2022 | -17.02% |
| Q2 2022 | 40.88% |
| Q1 2022 | -121.84% |
| Q4 2021 | -323.79% |
| Q3 2021 | -8132.89% |
| Q2 2021 | 0.00% |